| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.0077 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |